Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Iowa variant of familial Alzheimer's disease: accumulation of posttranslationally modified AbetaD23N in parenchymal and cerebrovascular amyloid deposits.
Yasushi Tomidokoro; Agueda Rostagno; Thomas A Neubert; Yun Lu; G William Rebeck; Blas Frangione; Steven M Greenberg; Jorge Ghiso (Profiled Author: Frangione, Blas)
Department of Pathology and Psychiatry, New York University School of Medicine, New York, NY 10016, USA.
The American journal of pathology 2010;176(4):1841-54.
Mutations within the amyloid-beta (Abeta) sequence, especially those clustered at residues 21-23, which are linked to early onset familial Alzheimer's disease (AD), are primarily associated with cerebral amyloid angiopathy (CAA). The basis for this predominant vascular amyloid burden and the differential clinical phenotypes of cerebral hemorrhage/stroke in some patients and dementia in others remain unknown. The AbetaD23N Iowa mutation is associated with progressive AD-like dementia, often without clinically manifested intracerebral hemorrhage. Neuropathologically, the disease is characterized by predominant preamyloid deposits, severe CAA, and abundant neurofibrillary tangles in the presence of remarkably few mature plaques. Biochemical analyses using a combination of immunoprecipitation, mass spectrometry, amino acid sequence, and Western blot analysis performed after sequential tissue extractions to separately isolate soluble components, preamyloid, and fibrillar amyloid species indicated that the Iowa deposits are complex mixtures of mutated and nonmutated Abeta molecules. These molecules exhibited various degrees of solubility, were highly heterogeneous at both the N- and C-termini, and showed partial aspartate isomerization at positions 1, 7, and 23. This collection of Abeta species-the Iowa brain Abeta peptidome-contained clear imprints of amyloid clearance mechanisms yet highlighted the unique neuropathological features shared by a non-Abeta cerebral amyloidosis, familial Danish dementia, in which neurofibrillary tangles coexist with extensive pre-amyloid deposition in the virtual absence of fibrillar lesions. These data therefore challenge the importance of neuritic plaques as the sole contributors for the development of dementia.
4 Originating Grant
-
1.
Gandy, Samuel E
Interdisciplinary Approach to Alzheimer Drug Discovery
30 September 1991 - 31 August 2010
NATIONAL INSTITUTE ON AGING
Total Funding: $ 11,063,275
-
2.
GREENGARD, PAUL
INTERDISCIPLINARY APPROACH TO ALZHEIMER DRUG DISCOVERY
30 September 1991 - 31 July 1996
NATIONAL INSTITUTE ON AGING
Total Funding: $ 2,198,300
-
3.
Frangione, Blas
Amyloidosis and Alzheimer's Disease
1 July 1985 - 30 June 2007
NATIONAL INSTITUTE ON AGING
Total Funding: $ 4,467,436
-
4.
FRANGIONE, BLAS
AMYLOIDOSIS AND ALZHEIMERS DISEASE
1 July 1985 - 30 June 1997
NATIONAL INSTITUTE ON AGING
Total Funding: $ 3,049,140
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Grants
-
1.
Teplow, David B
Formation and Function of Prefibrillar ABeta Assemblies
1 June 2003 - 31 May 2008
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 2,395,806
-
2.
GANDY, SAMUEL E
Phase 11-Grape Seed Extract as Anti-Oligomerization Agent in Alzheimer's Disease
15 September 2010 - 30 June 2014
NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE
Total Funding: $ 241,601
-
3.
MAYEUX, RICHARD
Epidemiology of Biomarkers of Risk and Progression in LOAD
1 May 2010 - 30 April 2015
NATIONAL INSTITUTE ON AGING
Total Funding: $ 5,932,714
Related Publications
-
1.
2009I Alafuzoff; L Aho; S Helisalmi; A Mannermaa; H Soininen
Beta-amyloid deposition in brains of subjects with diabetes.
Neuropathology and applied neurobiology 2009;35(1):60-8. -
2.
1992B T Hyman; R E Tanzi
Amyloid, dementia and Alzheimer's disease.
Current opinion in neurology and neurosurgery 1992;5(1):88-93. -
3.
2003D Strozyk; K Blennow; L R White; L J Launer
CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study.
Neurology 2003;60(4):652-6.
Related Topics
Appears in this Publication
Related Experts
Author of this Publication
-
Internal ExpertsPublications
-
411









-
505









-
571









-
321









-
416









-
525









